ProMIS Neurosciences Inc.
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.80 | – | -13.17 | -1.90 | -5.55 | -5.91 | -3.53 | -2.76 | -7.30 | -5.15 | -1.90 | -1.14 | -4.59 | |
| 0.00 | – | 0.02 | 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | – | |
| 0.00 | – | 0.08 | 0.02 | 0.10 | 0.45 | 0.18 | 0.15 | 0.14 | 487.75 | 0.03 | 0.04 | 93.82 | |
| 0.12 | – | -8.62 | 1.47 | -2.16 | -2.41 | 1.56 | 4.34 | 0.95 | 0.84 | -0.66 | 0.10 | -0.07 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.16 | – | 0.00 | – | – | 0.00 | – | – | – | 0.00 | – | – | – | |
| – | – | -0.87 | – | – | – | – | – | – | – | – | – | – | |
| 36.90 | – | 0.24 | 0.00 | 22.63 | 0.01 | 0.00 | 0.00 | 15.25 | -0.16 | 10.74 | 0.00 | 9.96 | |
| 31.62 | – | -12.93 | -1.90 | 17.08 | -5.92 | -3.53 | -2.76 | 7.81 | -5.28 | 8.84 | -1.14 | 5.35 | |
| -4.80 | – | -13.17 | -1.90 | -5.55 | -5.91 | -3.53 | -2.76 | -7.30 | -5.15 | -1.90 | -1.14 | -4.59 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.